Announcements Trials
Browse Landscape

Phase

Phase NA 117Phase 2 24Phase 1 11Phase 3 8Phase EARLY_PHASE1 5Phase 4 4Phase 1/2 4Phase 2/3 1

Status

Completed 4Terminated 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

NET 1Gynecologic 1Genitourinary 1Endocrine 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Urologic Neoplasms 1Neuroendocrine Tumors 1Breast Neoplasms 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Completed × Surveys and Questionnaires × Clear all
NCT03289741 2025-05-09

A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Memorial Sloan Kettering Cancer Center

Phase 4 Completed
51 enrolled 10 charts
EndocrineNET

Neuroendocrine Tumors

NCT03210376 2020-11-25

Neuromuscular Blockade on Shoulder Pain of Elderly

M.D. Anderson Cancer Center

Phase 4 Completed
100 enrolled 17 charts
Genitourinary

Urologic Neoplasms

NCT02502864 2020-09-11

Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide

H. Lee Moffitt Cancer Center and Research Institute

Phase 4 Completed
9 enrolled 9 charts
Breast

Breast Neoplasms

NCT02837926 2019-04-10

CoheaHr-WP4

CHU de Reims

Phase 4 Completed
63 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡